Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [1]
- Immunoprecipitation [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 14563-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#14563-1-AP, RRID:AB_2076740
- Product name
- CDR2L antibody
- Antibody type
- Polyclonal
- Description
- CDR2L antibody (Cat. #14563-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IF, IHC, IP,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Expression of cerebellar degeneration-related proteins CDR2 and CDR2L in human and rat brain tissue.
Localization of CDR2L and CDR2 in paraneoplastic cerebellar degeneration.
Cerebellar degeneration-related proteins 2 and 2-like are present in ovarian cancer in patients with and without Yo antibodies.
Paraneoplastic CDR2 and CDR2L antibodies affect Purkinje cell calcium homeostasis.
Raspotnig M, Kråkenes T, Herdlevær I, Haugen M, Vedeler C
Journal of neuroimmunology 2022 Jan 15;362:577766
Journal of neuroimmunology 2022 Jan 15;362:577766
Localization of CDR2L and CDR2 in paraneoplastic cerebellar degeneration.
Herdlevaer I, Kråkenes T, Schubert M, Vedeler CA
Annals of clinical and translational neurology 2020 Nov;7(11):2231-2242
Annals of clinical and translational neurology 2020 Nov;7(11):2231-2242
Cerebellar degeneration-related proteins 2 and 2-like are present in ovarian cancer in patients with and without Yo antibodies.
Raspotnig M, Haugen M, Thorsteinsdottir M, Stefansson I, Salvesen HB, Storstein A, Vedeler CA
Cancer immunology, immunotherapy : CII 2017 Nov;66(11):1463-1471
Cancer immunology, immunotherapy : CII 2017 Nov;66(11):1463-1471
Paraneoplastic CDR2 and CDR2L antibodies affect Purkinje cell calcium homeostasis.
Schubert M, Panja D, Haugen M, Bramham CR, Vedeler CA
Acta neuropathologica 2014 Dec;128(6):835-52
Acta neuropathologica 2014 Dec;128(6):835-52
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- SH-SY5Y cells were subjected to SDS PAGE followed by western blot with 14563-1-AP(CDR2L antibody) at dilution of 1:500
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The CDR2L antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human CDR2L. This antibody recognizes human,mouse,rat antigen. The CDR2L antibody has been validated for the following applications: ELISA, WB, IP, IF analysis.
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- IP Result of anti-CDR2L (IP:14563-1-AP, 3ug; Detection:14563-1-AP 1:500) with SH-SY5Y cells lysate 2500ug.
- Sample type
- cell line